Open

Coming up

Don't miss

Replay


LATEST SHOWS

BUSINESS DAILY

Scottish fishing industry divided over independence

Read more

DEBATE

Hollande on his own? Socialist backbenchers abstain on confidence vote

Read more

DEBATE

Hollande on his own? Socialist backbenchers abstain on confidence vote (part 2)

Read more

MEDIAWATCH

Ukraine politician thrown on rubbish heap

Read more

THE INTERVIEW

'Iraq wants role for Iran in anti-IS coalition', says foreign minister

Read more

ENCORE!

Margaret Atwood: A Prophetic Writer in Paris

Read more

FOCUS

Italy: The search for missing migrants

Read more

WEB NEWS

News media urged not to show Islamic State group videos

Read more

IN THE PAPERS

Is Valls crying wolf?

Read more

Europe

All countries will need vaccine for 'unstoppable' flu, says WHO

Video by Bénédicte PAVIOT

Latest update : 2009-07-13

A World Health Organisation director said on Monday that the influenza A (H1N1) virus was so virulent that every nation would have to make vaccines available. Meanwhile, in the UK, two more have died of the virus, bringing their national total to 17.

REUTERS - The new H1N1 influenza virus bears a disturbing resemblance to the virus strain that caused the 1918 flu pandemic, with a greater ability to infect the lungs than common seasonal flu viruses, researchers reported on Monday.

 

Tests in several animals confirmed other studies that have shown the new swine flu strain can spread beyond the upper respiratory tract to go deep into the lungs—making it more likely to cause pneumonia, the international team said.

 

In addition, they found that people who survived the 1918 pandemic seem to have extra immune protection against the virus, again confirming the work of other researchers.

 

“When we conducted the experiments in ferrets and monkeys, the seasonal virus did not replicate in the lungs,” said Yoshihiro Kawaoka of the University of Wisconsin, who led the study.

 

The H1N1 virus replicates significantly better in the lungs.”

 

The new swine flu virus has caused the first pandemic of the 21st century, infecting more than a million people, according to estimates, and killing at least 500. The World Health Organization says it is causing mostly moderate disease but Kawaoka said that does not mean it is like seasonal flu.

 

“There is a misunderstanding about this virus,” he said in a statement. “There is clear evidence the virus is different than seasonal influenza.”

 

Writing in the journal Nature, Kawaoka and colleagues noted that the ability to infect the lungs is a characteristic of other pandemic viruses, especially the 1918 virus, which is estimated to have killed between 40 million and 100 million people.

 

Old protection

 

They tested the virus in blood samples taken from nursing home residents and workers in 1999 in California, Wisconsin, the Netherlands and Japan.

 

People born before 1920 had a strong antibody response to the new H1N1 virus, meaning their body “remembered” it from infection early in life. This finding supports a study published in Nature in August that also found people who survived the 1918 pandemic still had immune protection against that virus.

 

Flu viruses change constantly, which is why people can be re-infected and why the vaccine must be changed regularly.

 

Current seasonal strains of H1N1 are distant cousins of both the 1918 pandemic strain and the new H1N1 strain.

 

“Our findings are a reminder that swine-origin influenza viruses have not yet garnered a place in history, but may still do so, as the pandemic caused by these viruses has the potential to produce a significant impact on human health and the global economy,” the researchers wrote.

 

Other tests showed the virus could be controlled by the antiviral drugs Relenza, made by GlaxoSmithKline, and Tamiflu, made by Roche AG, the researchers said.

 

The World Health Organization said on Monday that vaccine makers should start making immunizations against H1N1 and that healthcare workers should be first in line to get them.

 

Companies working on an H1N1 vaccine include Sanofi-Aventis, Novartis AG, Baxter International Inc, GlaxoSmithKline, Solvay and nasal spray maker MedImmune, now part of AstraZeneca.


 

Date created : 2009-07-13

COMMENT(S)